🚀 VC round data is live in beta, check it out!

Lifevantage Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lifevantage and similar public comparables like Bridgford Foods, Helio, New Zealand King Salmon, Centrale del Latte and more.

Lifevantage Overview

About Lifevantage

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.


Founded

1988

HQ

United States

Employees

238

Financials (LTM)

Revenue: $198M
EBITDA: $17M

EV

$70M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lifevantage Financials

Lifevantage reported last 12-month revenue of $198M and EBITDA of $17M.

In the same LTM period, Lifevantage generated $156M in gross profit, $17M in EBITDA, and $8M in net income.

Revenue (LTM)


Lifevantage P&L

In the most recent fiscal year, Lifevantage reported revenue of $229M and EBITDA of $22M.

Lifevantage is profitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 10%, and net margin of 4%.

See analyst estimates for Lifevantage
LTMLast FY202320242025202620272028
Revenue$198M$229M$207M$214M$211M
Gross Profit$156M$184M$164M$171M$167M
Gross Margin79%80%79%80%79%
EBITDA$17M$22M$8M$12M$16M
EBITDA Margin9%10%4%5%8%
EBIT Margin5%5%2%4%5%
Net Profit$8M$10M$3M$6M$9M
Net Margin4%4%1%3%4%

Financial data powered by Morningstar, Inc.

Lifevantage Stock Performance

Lifevantage has current market cap of $69M, and enterprise value of $70M.

Market Cap Evolution


Lifevantage's stock price is $5.40.

Lifevantage share price increased by 6.9% in the last 30 days, and decreased by 58.6% in the last year.

Lifevantage has an EPS (earnings per share) of $0.77.

See more trading valuation data for Lifevantage
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$70M$69M0.0%6.9%16.1%-58.6%$0.77

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lifevantage Valuation Multiples

Lifevantage trades at 0.4x EV/Revenue multiple, and 4.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Lifevantage

EV / Revenue (LTM)


Lifevantage Financial Valuation Multiples

As of May 3, 2026, Lifevantage has market cap of $69M and EV of $70M.

Lifevantage has a P/E ratio of 8.3x.

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.3x0.3x0.3x0.3x
EV/EBITDA4.0x3.2x8.8x6.0x4.4x
EV/EBIT7.3x5.5x16.2x8.4x6.6x
EV/Gross Profit0.4x0.4x0.4x0.4x0.4x
P/E8.3x7.1x25.2x10.9x7.7x
EV/FCF218.2x6.6x10.2x6.8x13.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lifevantage Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lifevantage Margins & Growth Rates

Lifevantage decreased revenue by 16% and EBITDA by 26% in the last fiscal year.

In the most recent fiscal year, Lifevantage reported gross margin of 80%, EBITDA margin of 10%, and net margin of 4%.

See estimated margins and future growth rates for Lifevantage

Lifevantage Margins

Last FY202420252026202720282029
Gross Margin80%80%79%79%
EBITDA Margin10%5%8%9%
EBIT Margin5%4%5%5%
Net Margin4%3%4%4%
FCF Margin5%5%2%0%

Lifevantage Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(16%)4%(2%)(9%)
Gross Profit Growth(18%)4%(2%)(10%)
EBITDA Growth(26%)48%36%7%
EBIT Growth(29%)92%28%(12%)
Net Profit Growth(18%)133%40%(11%)
FCF Growth(103%)49%(50%)(82%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Lifevantage Operational KPIs

Lifevantage's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.7M for the same period.

Lifevantage's Rule of 40 is (0%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lifevantage's Rule of X is (13%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Lifevantage
LTMLast FY202320242025202620272028
Rule of 405%(0%)———
Bessemer Rule of X(0%)(13%)———
Revenue per Employee—$1.0M———
Opex per Employee—$0.7M———
G&A Expenses to Revenue—30%34%32%33%
Opex to Revenue—75%77%76%81%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lifevantage Competitors

Lifevantage competitors include Bridgford Foods, Helio, New Zealand King Salmon, Centrale del Latte, Skane-Mollan, Groupe Carnivor, Makarony Polskie, Loulis Food Ingredients, Premium Snacks Nordic and Saint Jean Groupe.

Most Lifevantage public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bridgford Foods0.3x—(6.0x)—
Helio0.7x—11.0x—
New Zealand King Salmon0.4x0.5x3.1x5.4x
Centrale del Latte0.0x—0.4x—
Skane-Mollan2.3x—30.7x—
Groupe Carnivor0.3x—9.8x—
Makarony Polskie0.7x0.7x3.5x3.8x
Loulis Food Ingredients————

This data is available for Pro users. Sign up to see all Lifevantage competitors and their valuation data.

Start Free Trial

Lifevantage M&A Activity

Lifevantage has acquired 1 company to date.

Last acquisition by Lifevantage was on September 3rd 2025. Lifevantage acquired LoveBiome for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Lifevantage

LoveBiome
Description
LoveBiome is a health supplement company producing microbiome-supporting products from superfruits and superfoods. Its lineup includes probiotic powders, capsules, and drinks fermented with kiwi, pineapple, and berry extracts to promote gut balance and digestion. Sold online and in health stores, the formulations target immunity, skin health, and energy without synthetic additives. Headquartered in New Zealand, LoveBiome ships internationally.
HQ CountryUnited States
HQ City
Provo, UT
Deal Date3 Sep 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lifevantage acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lifevantage

When was Lifevantage founded?Lifevantage was founded in 1988.
Where is Lifevantage headquartered?Lifevantage is headquartered in United States.
How many employees does Lifevantage have?As of today, Lifevantage has over 238 employees.
Who is the CEO of Lifevantage?Lifevantage's CEO is Steven R. Fife.
Is Lifevantage publicly listed?Yes, Lifevantage is a public company listed on Nasdaq.
What is the stock symbol of Lifevantage?Lifevantage trades under LFVN ticker.
When did Lifevantage go public?Lifevantage went public in 1997.
Who are competitors of Lifevantage?Lifevantage main competitors include Bridgford Foods, Helio, New Zealand King Salmon, Centrale del Latte, Skane-Mollan, Groupe Carnivor, Makarony Polskie, Loulis Food Ingredients, Premium Snacks Nordic, Saint Jean Groupe.
What is the current market cap of Lifevantage?Lifevantage's current market cap is $69M.
What is the current revenue of Lifevantage?Lifevantage's last 12 months revenue is $198M.
What is the current revenue growth of Lifevantage?Lifevantage revenue growth (NTM/LTM) is (4%).
What is the current EV/Revenue multiple of Lifevantage?Current revenue multiple of Lifevantage is 0.4x.
Is Lifevantage profitable?Yes, Lifevantage is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Lifevantage?Lifevantage's last 12 months EBITDA is $17M.
What is Lifevantage's EBITDA margin?Lifevantage's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Lifevantage?Current EBITDA multiple of Lifevantage is 4.0x.
What is the current FCF of Lifevantage?Lifevantage's last 12 months FCF is $319K.
What is Lifevantage's FCF margin?Lifevantage's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of Lifevantage?Current FCF multiple of Lifevantage is 218.2x.
How many companies Lifevantage has acquired to date?As of May 2026, Lifevantage has acquired 1 company.
What was the largest acquisition by Lifevantage?None of the M&A deals Lifevantage has completed have disclosed valuations.
What companies Lifevantage acquired?Lifevantage acquired LoveBiome.
In how many companies Lifevantage has invested to date?Lifevantage hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Lifevantage

Lists including Lifevantage

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial